Wire Stories
Propanc Biopharma Provides Upcoming Milestones
Entering Phase IB First-In-Human Study, Pipeline Expansion & Potential Acquisition Opportunity MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTCQB: PPCB) (�Propanc� or the �Company�),...